Maximum Dose of Midodrine
The maximum recommended dose of midodrine is 30 mg per day (10 mg three times daily), though single doses up to 20 mg have been used in clinical practice, and total daily doses exceeding 30 mg have been tolerated in select cases. 1
FDA-Approved Maximum Dosing
The FDA drug label establishes clear dosing parameters 1:
- Standard maximum: 10 mg three times daily (30 mg/day total)
- Dosing interval: Approximately 4-hour intervals during daytime hours
- Single dose maximum: Up to 20 mg has been given, but severe supine hypertension occurs at high rates (~45%) at this dose
- Critical timing restriction: Last dose should be taken no later than 6 PM and at least 4 hours before bedtime to minimize supine hypertension during sleep
Total daily doses greater than 30 mg have been tolerated by some patients, but their safety and usefulness have not been systematically studied or established. 1
Guideline-Based Dosing Recommendations
The European Heart Journal guidelines recommend midodrine 5-20 mg three times daily for orthostatic hypotension 2, while the Canadian Cardiovascular Society recommends 2.5-15 mg every 4 hours up to 3 times per day for POTS 3. Both align with the FDA's 30 mg/day ceiling as the standard maximum.
Special Populations Requiring Dose Adjustment
Renal impairment: Treatment should be initiated at 2.5 mg doses due to renal excretion of the active metabolite desglymidodrine 1. Renal function must be assessed before initiating therapy.
Hepatic impairment: Use with caution as the liver plays a role in metabolism, though specific dosing adjustments are not established 1.
Higher Doses in Clinical Practice
While not FDA-approved, case reports document successful use of higher doses:
- One case report described a patient with end-stage renal disease on hemodialysis tolerating 90 mg daily (60 mg maintenance + 30 mg intradialytic) for treprostinil-induced hypotension without adverse effects 4
- This represents the highest reported daily dose in the literature, but should be considered exceptional rather than standard practice
Critical Safety Considerations
Supine hypertension is the dose-limiting adverse effect:
- Monitor supine and standing blood pressure regularly 1
- Discontinue if supine blood pressure increases excessively
- Risk increases substantially with single doses ≥20 mg
Other adverse effects include 5, 6:
- Pilomotor reactions (piloerection, "goosebumps")
- Urinary retention
- Bradycardia (reported in 46% of patients in some studies) 7
Practical Dosing Algorithm
- Start: 2.5-5 mg three times daily (or 10 mg TID if normal renal/hepatic function)
- Titrate: Increase by 2.5-5 mg per dose based on blood pressure response and symptom control
- Target: 10 mg three times daily (30 mg/day) as standard maximum
- Timing: Administer upon arising, midday, and late afternoon (not after 6 PM)
- Monitor: Check supine and standing BP regularly; discontinue if excessive supine hypertension develops
Do not exceed 30 mg/day without compelling clinical justification and close monitoring, as safety beyond this dose is not established. 1